Peptides like this one are fragile molecules, and an injectable, subcutaneous form is generally the most predictable way to deliver a known, stable amount into the body
They also have a higher density of estrogen receptors, which affects fat distribution, and experience pronounced age-related collagen decline, reducing skin firmness
doi: 10.1038/s41467-020-14309-w Ast J, Novak AN, Podewin T, Fine NHF, Jones B, Tomas A, Birke R, Romann K, Mathes B, Eichhorst J, Lehmann M, Linnemann AK, Hodson DJ, Broichhagen J
Blood pressure-lowering effect of newer antihyperglycemic agents (SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors)
If Novo were to lose such a case based on a judgment of patent invalidity, it could potentially lose its exclusive rights to semaglutide, meaning that others (not just Hims) would be free to use, make, and sell it without infringing